FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype
about
Integrated computational approach to the analysis of RNA-seq data reveals new transcriptional regulators of psoriasis.A computational systems approach identifies synergistic specification genes that facilitate lineage conversion to prostate tissueNFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.Stromal androgen receptor in prostate development and cancer.Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.Nfib Regulates Transcriptional Networks That Control the Development of Prostatic HyperplasiaThe essential role of GATA transcription factors in adult murine prostate.Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo.Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer.Intrauterine exposure to oestradiol promotes sex-specific differential effects on the prostatic development of neonate gerbils.Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation.FOXA1 inhibits prostate cancer neuroendocrine differentiation.Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cellsFox transcription factors: from development to disease.Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.Tyrosine Phosphorylation of the Pioneer Transcription Factor FoxA1 Promotes Activation of Estrogen Signaling.Interaction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo.
P2860
Q31140838-63F5D921-C91F-458B-9D00-3448042BAF65Q33628916-F7B67CD5-58C6-4D0C-8252-FB62C8949BE9Q33701352-D58C0CAF-8E6C-485C-9594-CF527FB7585EQ34302834-845DB2B3-A1C7-4914-9162-196CF1C9FE46Q35380380-6B525818-798F-4519-B177-A13143DB12A8Q35568071-04EC926C-43E1-46F6-8731-4F1D02EA767FQ36625094-009F7A3A-7F7B-4DE5-87B9-9385EEA1F246Q37565312-9C654A1A-3379-4175-A4D7-6142704060DAQ37688544-35D4B0AB-488C-433D-9034-A5F7C95E4A50Q38538387-98C32974-1B31-47E0-8DA9-91FD47F3BEF2Q38662731-A52BA603-9D58-4655-B177-EFF1DC25723BQ38762535-C21C34D1-514E-4B97-B687-6F0EB5E154DDQ38893882-7D3C751B-7B01-4E1C-A1DF-A6295F4432A1Q38976815-001FED06-08F5-4CDA-99A2-8DBBE510DB8EQ39037983-329F5AA5-1611-4700-A06A-57693D0C74A9Q39235902-64A9D3D7-9F42-4A18-8402-12080BAC65BAQ51305858-13A44899-E298-4268-9012-335153DED5CDQ52550597-B15DAEE4-52CB-4D74-9F2F-3742B371FDBF
P2860
FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
FOXA1 deletion in luminal epit ...... on of differentiated phenotype
@en
type
label
FOXA1 deletion in luminal epit ...... on of differentiated phenotype
@en
prefLabel
FOXA1 deletion in luminal epit ...... on of differentiated phenotype
@en
P2093
P2860
P50
P1476
FOXA1 deletion in luminal epit ...... on of differentiated phenotype
@en
P2093
David J DeGraff
Klaus H Kaestner
Magdalena M Grabowska
Mary K Herrick
Michael A Walter
Ralph Buttyan
Robert J Matusik
Simon W Hayward
Tom C Case
P2860
P2888
P304
P356
10.1038/LABINVEST.2014.64
P577
2014-05-19T00:00:00Z